SYNERGY PHARMACEUTICALS DEL (SGYP) Stock Price, Quote, News and Overview
NASDAQ:SGYP - Nasdaq -
SGYP Quote, Performance and Key Statistics
0.03
-0.03 (-52%)
The current stock price of SGYP is 0.03 null. In the past month the price decreased by -90.32%. In the past year, price decreased by -98.62%.
About SGYP
Company Profile
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant- irritable bowel syndrome. It is also engaged in developing receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals, Inc. is headquartered in New York, New York.
Company Info
SYNERGY PHARMACEUTICALS DEL
420 LEXINGTON AVENUE SUITE 2012
NEW YORK NY 10170
CEO: Troy Hamilton
Phone: 212-297-0020
SYNERGY PHARMACEUTICALS DEL / SGYP FAQ
What is the stock price of SYNERGY PHARMACEUTICALS DEL today?
The current stock price of SGYP is 0.03 null. The price decreased by -52% in the last trading session.
What is the ticker symbol for SYNERGY PHARMACEUTICALS DEL stock?
The exchange symbol of SYNERGY PHARMACEUTICALS DEL is SGYP and it is listed on the Nasdaq exchange.
On which exchange is SGYP stock listed?
SGYP stock is listed on the Nasdaq exchange.
What is SYNERGY PHARMACEUTICALS DEL worth?
SYNERGY PHARMACEUTICALS DEL (SGYP) has a market capitalization of 7.44M null. This makes SGYP a Nano Cap stock.
Should I buy SYNERGY PHARMACEUTICALS DEL (SGYP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SGYP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SGYP, evaluating the profitability, health, valuation and growth aspects
- SYNERGY PHARMACEUTICALS DEL (SGYP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SYNERGY PHARMACEUTICALS DEL (SGYP) Sales and EPS estimates to see what analysts future expectations are.
- SYNERGY PHARMACEUTICALS DEL (SGYP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SYNERGY PHARMACEUTICALS DEL (SGYP) Insider and Institutional Ownership to learn about the owners and their transactions.
- SYNERGY PHARMACEUTICALS DEL (SGYP) Stock Chart to make your own analysis
- SYNERGY PHARMACEUTICALS DEL (SGYP) Latest news and press-releases to stay up to date.
Does SYNERGY PHARMACEUTICALS DEL (SGYP) stock pay dividends?
SGYP does not pay a dividend.
What is the Price/Earnings (PE) ratio of SYNERGY PHARMACEUTICALS DEL (SGYP)?
SYNERGY PHARMACEUTICALS DEL (SGYP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).
SGYP Technical Analysis
SGYP Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SGYP. While SGYP is still in line with the averages on profitability rating, there are concerns on its financial health.
SGYP Financial Highlights
Over the last trailing twelve months SGYP reported a non-GAAP Earnings per Share(EPS) of -0.5900000000000001. The EPS increased by 49.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -332.11% | ||
| ROA | -165.36% | ||
| ROE | 142.67% | ||
| Debt/Equity | 0 |